Table 2

QOL and adverse events

SCT groupControl groupP value*
Anxiety (SAS) score
 Before treatment38.5 ± 7.138.3 ± 9.3NS
 After treatment34.6 ± 5.439.7 ± 8.90.0053
Depression (SDS) score
 Before treatment38.0 ± 6.640.4 ± 6.6NS
 After treatment33.3 ± 4.739.7 ± 6.30.0091
QOL (SF-36) score
 Before treatment78.6 ± 8.479.4 ± 8.1NS
 After treatment82.4 ± 5.978.6 ± 7.90.0368
Adverse event typeURTIBleedingAbdominal painURTI
 Number of occurrences7*1*1*5
 Time after treatment (months)3 (1–6)004 (2–6)
Adverse event gradeMildMildMildMild
 AttributionUnrelatedDefiniteDefiniteUnrelated
 InterventionMedicalLocal pressureNoneMedical
 OutcomeResolvedResolvedResolvedResolved
  • Data are mean ± SD or mean (range). SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; SF-36, Medical Outcomes Study 36-Item Short-Form Survey; URTI, upper respiratory tract infection.

  • *P < 0.05 compared with the occurrence rate in the control group.

  • †Occurred in the ward 3 h after the arterial intervention therapy because the patient did not adhere to counseling.

  • ‡Occurred during the arterial intervention therapy, which was transient and recovered without intervention after transplantation.